Skip to Main Content

NISH (NITAG Support Hub) 2: Covid-19 vaccine hesitancy/confidence in Africa

This Library Guide contains published and unpublished information on vaccine hesitancy and related issues in the context of COVID-19 vaccination in Subsaharan Africa

Google Scholar

Butler, N., Roldan de Jong, T., Muzzulini, B. and Tulloch, O., 2022. Key Considerations: Improving Uptake of the COVID-19 Vaccine Amongst Women in South Sudan.
 
Udoh, K., 2022. COVID-19 Vaccine Hesitancy in South Sudan; What Lessons Can be Learned From Angola’s Success Story?. American Journal of Health Promotion, 36(3), pp.579-581.(Not OA)
Abstract:
COVID-19 is a respiratory disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 and although most people who contract the disease do not show any symptoms, some experience blood clots, multi-organ failure, and septic shock, which may lead to death. 1,2 Globally, by 19th July 2021, there were 190 314 629 confirmed cases and 4 092 740 deaths, reported to World Health Organisation (WHO). 3 Although in South Sudan, a country in East Africa, there were only 10 917 cases with 117 deaths (approximately).006% and .003% of global figures, respectively) by 23rd July 2021, it appears that these prevalence and mortality data may be understated, reflecting the limited surveillance, and testing capacities in the
country. Like other countries, South Sudans Ministry of Health has advocated for adherence to WHO-recommended preventive measures like handwashing, mask-wearing, and social-distancing, to curb the spread of COVID-19. 5 However, poor adherence remains a challenge due to factors related to the countrys history of civil conflicts including health system challenges such as insufficient health funding and human resources for health. Other factors like poverty and illiteracy, which are well-established predictors of poor adherence to public health prevention measures, are also prevalent in South Sudan, with 76% of the population living in poverty (ie, at US$1.90 a day, 2011 purchasing power parity) and an adult literacy rate of 35%
 
Soeters, H.M., Doshi, R.H., Fleming, M., Adegoke, O.J., Ajene, U., Aksnes, B.N., Bennett, S., Blau, E.F., Carlton, J.G., Clements, S. and Conklin, L., 2022. CDC’s COVID-19 International Vaccine Implementation and Evaluation program and lessons from earlier vaccine introductions. Emerging infectious diseases, 28(Suppl 1), pp.S208-S216.
 

Hlongwa, M., Afolabi, A. and Dzinamarira, T., 2022. Hesitancy towards a COVID-19 vaccine in selected countries in Africa: Causes, effects and strategies for improving COVID-19 vaccine uptake. Global Biosecurity, 3(1).

https://drum.lib.umd.edu/bitstream/handle/1903/29051/SSHAP%20Rapid%20Review_Vaccine%20Hesitancy%20and%20Building%20Confidence%20in%20COVID-19%20Vaccination%20.pdf?sequence=1

Hlongwa, M., Afolabi, A. and Dzinamarira, T., 2022. Hesitancy towards a COVID-19 vaccine in selected countries in Africa: Causes, effects and strategies for improving COVID-19 vaccine uptake. Global Biosecurity, 3(1).
 
Acharya, K.P., Ghimire, T.R. and Subramanya, S.H., 2021. Access to and equitable distribution of COVID-19 vaccine in low-income countries. npj Vaccines, 6(1), p.54.